[186Re]-labeled mouse and chimeric monoclonal antibody 323/A3: a comparison of the efficacy in experimental human ovarian cancer.
- 1 January 1998
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 25 (1) , 37-45
- https://doi.org/10.1016/s0969-8051(97)00154-6
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparison of the biodistribution and the efficacy of monoclonal antibody labeled with either 131I or 186Re in human ovarian cancer xenograftsInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Determination of tumor-related factors of influence on the uptake of the monoclonal antibody 323/A3 in experimental human ovarian cancerInternational Journal of Cancer, 1997
- Rapid elimination of mouse/human chimeric monoclonal antibodies in nude miceCancer Immunology, Immunotherapy, 1997
- Modification of antibody isoelectric point affects biodistribution of 111-indium-labeled antibodyNuclear Medicine and Biology, 1996
- Comparison of the monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenograftsBritish Journal of Cancer, 1996
- Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinomaThe Lancet, 1994
- Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.The Journal of cell biology, 1994
- The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: An autoradiographic studyCancer Immunology, Immunotherapy, 1991
- EGS4 Monte Carlo determination of the beta dose kernel in waterMedical Physics, 1990
- Immunoglobulin G: Functional sitesMolecular Immunology, 1985